Clinical Trial

Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

Name: Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin — clinical trial record (NCT07362030)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and

Trial Details

NCT Number	NCT07362030
Lead Sponsor	Guangdong Raynovent Biotech Co., Ltd
Conditions	Obesity
Enrollment	32 participants
Start Date	2025-04-14
Primary Completion	2025-12-27 (estimated)
Study Completion	2026-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-23